|
⚲
|
| Keyboard |
| Matthews Andrea
✚
|
|
|---|---|
| CIK # | 0001973349 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001973349] | |
| 4 | [0001973349] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Catabasis Pharmaceuticals Inc | |
| Matthews Andrea |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 20,000 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 32,812 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 262,500 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2025-03-21 | Grant | 262,500 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2024-02-08 | Grant | 175,000 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2023-06-02 | Grant | 60,000 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2023-04-17 | Grant | 20,000 | $0.00 |